Normal layoutMedium LayoutLarge Layout Normal TextMedium TextLarge Text Search Site   
Home Me Family Gallery Research Events Articles Downloads Forums Contact
Articles Login  | Register
  1. Molecular mechanisms of death ligand-mediated immune modulation: A gene therapy model to prolong islet survival in type 1 diabetes. Sanlioglu AD, Griffith TS, Omer A, Dirice E, Sari R, Altunbas HA, Balci MK, and Sanlioglu S. J Cell Biochem 2008 June 1; 104(3):710-720.
 
  1. High levels of endogenous TRAIL expression correlate with increased cell death in human pancreas. Sanlioglu AD, Dirice E, Elpek O, Korcum AF, Balcı MK, Omer A, Griffith TS and Sanlioglu S. Pancreas 2008 May; 36(4):385-393.
 
  1. TRAIL-R4 decoy receptor gene expression is correlated with high Gleason scores, PSA recurrence and decreased survival in patients with prostate carcinoma. Koksal IT, Sanlioglu AD, Karacay B,Griffith TS and Sanlioglu S. Urologic Oncology 2008 Mar-Apr; 26(2):158-165.
 
  1. DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells. Sanlioglu AD, Karacay B,Koksal IT, Griffith TS and Sanlioglu S. Cancer Gene Therapy.2007 Dec; 14(12):976-984.
 
  1. Corneal protein nitration in experimental uveitis. Aslan M, Yucel I, Akar Y, Yücel G, Ciftcioglu MA and Sanlioglu S. Exp Biol Med (Maywood).2007 Nov; 232(10): 1308-1313.
 
  1. TRAIL death receptor-4 (DR4) expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma. Sanlioglu AD, Korcum AF, Pestereli E, Erdogan G, Karaveli S, Savas B, Griffith TS and Sanlioglu S. Int J Radiat Oncol Biol Phys. 2007 Nov; 69(3): 716-723.
 
  1. Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis.Terzioglu E, Bisgin A, Sanlioglu AD, Ulker M, Yazisiz V, Tuzuner S, and Sanlioglu S. Rheumatology (Oxford). 2007 May; 46(5): 783-789.
 
  1. A DcR2 siRNA strategy employing three different siRNA constructs in combination defeats adenovirus transferred TRAIL resistance in lung cancer cells. Aydin C, Sanlioglu AD, Karacay B, Ozbilim G, Dertsiz L, Ozbudak O, Akdis CA and Sanlioglu S. Human Gene Therapy. 2007 Jan; 18: 39-50.
 
  1. Dajani R, Sanlioglu S, Zhang Y, Li Q, Monick MM, Lazartigues E, Eggleston T, Davisson RL, Hunninghake GH, Engelhardt JF.Pleiotropic Functions of TNF alpha Determine Distinct IKK beta-Dependent Hepatocellular Fates in Response to LPS. Am J Physiol Gastrointest Liver Physiol. 2007 Jan; 292(1): G242-252.
 
  1. Differential expression of TRAIL and its receptors in benign and malignant prostate tissues. Sanlioglu AD, Koksal IT, Ciftcioglu MA, Baykara M, Luleci G and Sanlioglu S. Journal of Urology. 2007 Jan; 177(1): 359-364.
 
  1. Nitrotyrosine Formation and Apoptosis in Rat Models of Ocular Injury. Aslan M, Yucel I, Akar Y, Yücel G, Çiftçioglu MA and Sanlioglu S. Free Radical Research. 2006 Feb; 40(2): 147-153.
 
12. Adenovirus mediated IKKbKA expression sensitizes prostate carcinoma cells to TRAIL induced apoptosis. Sanlioglu AD, Koksal IT, Karacay B, Baykara M, Luleci G and Sanlioglu S. Cancer Gene Therapy. 2006 Jan; 13(1): 21-31.
 
13. Surface TRAIL decoy receptor-4 expression is correlated with TRAIL resistance in MCF7 breast cancer cells. Sanlioglu AD, Dirice E, Aydin C, Erin E, Koksoy S and Sanlioglu S. BMC Cancer. 2005 25;5(1):54.
 
  1. Differential PTEN protein expression profiles in superficial versus invasive bladder cancers. Koksal IT, Yasar D, Dirice E., Usta MF, Karauzum S, Luleci G, Baykara M and Sanlioglu S. Urol Int. 2005 75(2): 102-106 .
 
  1. The effect of cetirizine on IFN - g ve IL – 10 production in children with allergic rhinitis. Uguz A, Sanlioglu S, Yuzbey S,Coskun M,Yegin O. Turkish Journal of Pediatrics. 2005 47: 111-115.
 
16. Inhibition of the NF-kB Pathway Enhances TRAIL-Mediated Apoptosis in Neuroblastoma Cells. Karacay B, Sanlioglu S, Griffith TS, Sandler A and Bonthius DJ. Cancer Gene Therapy. 2004 Oct; 11(10): 681-690.
 
17. Novel approaches to augment adeno-associated virus type-2 endocytosis and transduction. Sanlioglu AD, Karacay B, Benson PK, Engelhardt JF and Sanlioglu S. Virus Research. 2004 Aug; 104(1): 51-59.
 
18. The assessment of PTEN tumor suppressor gene in combination with Gleason scoring and serum PSA to evaluate progression of prostate carcinoma. Koksal IT., Dirice E, Yasar D, Sanlioglu AD, Gulkesen KH, Ciftcioglu A., Ozes ON, Baykara M, Luleci G and Sanlioglu S. Urol Oncol. 2004 22(4): 307-312.
 
  1. Fundamental Principals of Tumor Necrosis Factor-alpha gene therapy approach and implications for patients with lung carcinoma. Sanlioglu AD, Aydin C, Bozcuk H, Terzioglu E and Sanlioglu S. Lung Cancer. 2004 44: 199-211.
 
20. Current progress in adenovirus mediated gene therapy for patients with prostate carcinoma. Sanlioglu AD, Koksal T, Baykara M, Luleci G, Karacay B, Sanlioglu S. Gene Ther Mol Biol. 2003 7: 113-133.
 
21. Genetic redox preconditioning differentially modulates AP-1 and NFkappaB responses following cardiac ischemia/reperfusion injury and protects against necrosis and apoptosis. Yang J, Marden JJ, Fan C, Sanlioglu S, Weiss RM, Ritchie TC, Davisson RL, Engelhardt JF. Molecular Therapy. 2003 Mar;7(3): 341-353.
 
22. First generation adenovirus vectors shorten survival time in a murine model of sepsis. Sanlioglu, S, Doerschug K, Flaherty, DM, Wilson RL, Yarovinsky TO, Monick MM, Engelhardt JF and Hunninghake GW. J. Immunology. 2002 169: 6539-6545.
 
  1. Mitochondrial K(ATP) channel openers activate the ERK kinase by an oxidant-dependent mechanism. Samavati L, Monick MM, Sanlioglu S, Buettner GR, Oberley LW, and Hunninghake GW. Am J Physiol Cell Physiol. 2002 Jul;283(1): C273-81.
 
24. Simultaneous inhibition of Rac1 and IKK Pathways sensitizes lung cancer cells to TNFa mediated apoptosis. Sanlioglu S, Luleci G and Thomas KW. Cancer Gene Therapy. 2001 8(11): 897-905.
 
25. GPx-1 gene delivery modulates NFkB activation following diverse environmental injuries through a specific subunit of the IKK complex. Li Q, Sanlioglu S, Li S, Ritchie T, Oberley L and Engelhardt JF. Antioxidant and Redox Signaling. 2001 3(3): 415-431.
 
26. LPS induces Rac1 dependent reactive oxygen species (ROS) formation and coordinates TNFa secretion through IKK regulation of NFkB. Sanlioglu S, Williams CM, Samavati L, Butler NS, Wang G, McCray PB, Ritchie TC, Hunninghake GW, Zandi E and Engelhardt JF. JBC. 2001 Aug 276(32): 30188-30198.
 
27. Rate Limiting Steps of AAV transduction and Implications for Human Gene Therapy. Sanlioglu S, MonickMM, Luleci G, Hunninghake GW and EngelhardtJF. Review. Current Gene Therapy.  2001 June; 1(2): 137-147.
 
28. Endocytosis and Nuclear Trafficking of Adeno-Associated Virus Type-2 is Controlled by Rac1/PI3-kinase Activation. Sanlioglu S, Benson PK, Yang J, Atkinson EM, Reynolds T and Engelhardt JF. Journal of Virology. 2000 Oct; 74(19): 9184-9196 (Cover illustration)
 
29. Loss of ATM Function Enhances Recombinant Adeno-Associated Virus Transduction and Integration through Pathways Similar to UV Irradiation. Sanlioglu S, Benson P, Engelhardt JF. Virology. 2000 Mar 1; 268(1): 68-78 (Cover illustration)
 
30. Two Independent Molecular Pathways for Recombinant Adeno-Associated virus genome conversion occur after UV-C and E4orf6 augmentation of transduction. Sanlioglu S, Duan D and Engelhardt JF. Human Gene Therapy. 1999 March 1;10(4): 591-602.
 
31. Cellular Redox State Alters Recombinant Adeno-Associated Virus Transduction Through Tyrosine Phosphatase Pathways. Sanlioglu S and Engelhardt JF. Gene Therapy. 1999 6: 1427-1437.
 
32. Formation of adeno-associated virus circular genomes is differentially regulated by adenovirus E4-ORF6 and E2a gene expression. Duan D, Sharma P, Dudus L, Zhang Y, Sanlioglu S, Yan Z, Yue Y, Lester R, Yang J, Fisher KJ, Engelhardt, J.F. Journal of Virology. 1999 73(1): 161-169.
 
33. Selective disruption of "late onset" sagittal banding patterns by ectopic expression of engrailed-2 in cerebellar Purkinje cells. Baader SL, Vogel MW, Sanlioglu S, Zhang X, Oberdick J. Journal of Neuroscience. 1999 Jul 1; 19(13): 5370-5379.
 
34. Regulation of a Purkinje cell-specific promoter by homeodomain proteins: repression by engrailed-2 vs. synergistic activation by Hoxa5 and Hoxb7. Sanlioglu S, Zhang X, Baader SL, Oberdick J.  Journal of Neurobiology. 1998 Sep 15; 36(4): 559-571.
 
35. Ectopic overexpression of engrailed-2 in cerebellar Purkinje cells causes restricted cell loss and retarded external germinal layer development at lobule junctions. Sanlioglu S, Baader SL, Berrebi AS, Parker-Thornburg J, Oberdick J. Journal of Neuroscience. 1998 Mar 1; 18(5): 1763-1773.
 
36. Functional cloning of candidate genes that regulate Purkinje cell-specific gene expression. Sanlioglu-Crisman S. and Oberdick J. Progress in Brain Research. 1997 114: 3-19.
 
37. Local control of granule cell generation by cerebellar Purkinje cells. Smeyne R, Chu T, Lewin A, Bian F, Sanlioglu-Crisman S, Kunsch C, Lira SA and Oberdick J. Mol Cell Neuroscience. 1995 6: 230-251.
 
38. Structure and genetics of the partially duplicated gene RP located immediately upstream of the complement C4A and C4B genes in the HLA class III region. Shen L, Wu LC, Sanlioglu S, Chen R, Mendoza AR, Dangel A, Carroll MC, Zipf WB, Yung CY. Journal of Biological Chemistry. 1994 269(11): 8466-8476.
 
39. Isolation of Acinetobacter lwoffi from hens with septicemia Kaya O, Ates M, Erganis O, Corlu M. and SanliogluS. Journal of Veterinary Medicine. 1989 36(2): 157-158.
   Copyright 2008 by Salih Sanlioglu VMD, PhD    Terms Of Use    Privacy Statement